This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dowler, J Search for Related Content PubMed Articles by Dowler, J

View 1: Should this patient receive laser treatment?

Series editors: Susan Lightman and Peter McCluskey

Moorfields Eye Hospital, City Road, London EC1V 2RD, UK; jonathan.dowler@moorfields.nhs.uk

Keywords: diabetic retinopathy; macular oedema; vision loss; vitrectomy

The first 150 words of the full text of this article appear below.

In patients with diabetic retinopathy, laser treatment is directed at the prevention of visual loss rather than at visual improvement. Treatment should therefore be applied before visual loss occurs, when the risk of visual loss justifies adverse effects of treatment. The risk of visual loss is linked to the likelihood of progression of retinopathy to sight threatening forms, which in turn depends on epidemiological factors such as sex, ethnicity, diabetes type, and duration; systemic factors such as hypertension, glycaemic control, and serum lipids; specific risk factors such as pregnancy, cataract surgery, and tightened glycaemic control; and, lastly, ophthalmoscopic signs (box 1).

Box Box 1 Factors influencing progression of diabetic retinopathy Epidemiological factors (immutable) Diabetes type, diabetes duration, ethnicity, sex Systemic factors (modifiable) Glycaemic control, hypertension, serum lipids, renal dysfunction Specific risk factors (timeable) Pregnancy, cataract surgery, tightened glycaemic control Ophthalmoscopic signs

 

This patient has type 2 diabetes, and data from the . . . [Full text of this article]